[Case of Long-Term Survival after Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma].

Q4 Medicine Japanese Journal of Cancer and Chemotherapy Pub Date : 2024-11-01
Satoru Matono, Takafumi Ohchi, Sho Setojima, Atsushi Kaibara, Naoki Mori, Kohei Saisho, Masashi Nakagawa, Haruhiro Hino, Nobuya Ishibashi, Toshiaki Tanaka, Fumihiko Fujita, Etsuyo Ogo
{"title":"[Case of Long-Term Survival after Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma].","authors":"Satoru Matono, Takafumi Ohchi, Sho Setojima, Atsushi Kaibara, Naoki Mori, Kohei Saisho, Masashi Nakagawa, Haruhiro Hino, Nobuya Ishibashi, Toshiaki Tanaka, Fumihiko Fujita, Etsuyo Ogo","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>67-year-old woman underwent definitive chemoradiotherapy( dCRT) with cisplatin( CDDP) and 5-fluorouraci(l 5-FU)(FP) for locally advanced unresectable squamous cell carcinoma of the thoracic esophagus. During treatment, the patient developed grade 3 pharyngitis and esophagitis as adverse events. She was administered maintenance chemotherapy with 2 courses of FP and achieved complete response. Currently, she experiences esophageal stenosis; however, she remains alive and recurrence-free 9 years after initial treatment. While dCRT is effective for locally advanced esophageal cancer, its adverse effects may persist. Herein, we report our case and have included relevant literature considerations.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"51 11","pages":"1161-1164"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Cancer and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

67-year-old woman underwent definitive chemoradiotherapy( dCRT) with cisplatin( CDDP) and 5-fluorouraci(l 5-FU)(FP) for locally advanced unresectable squamous cell carcinoma of the thoracic esophagus. During treatment, the patient developed grade 3 pharyngitis and esophagitis as adverse events. She was administered maintenance chemotherapy with 2 courses of FP and achieved complete response. Currently, she experiences esophageal stenosis; however, she remains alive and recurrence-free 9 years after initial treatment. While dCRT is effective for locally advanced esophageal cancer, its adverse effects may persist. Herein, we report our case and have included relevant literature considerations.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[无法切除的局部晚期食管鳞状细胞癌化疗后长期存活病例]
67岁的女性因局部晚期不可切除的胸食管鳞状细胞癌接受了顺铂(CDDP)和5-氟尿嘧啶(l 5-FU)(FP)的明确放化疗(dCRT)。在治疗期间,患者出现了3级咽炎和食管炎作为不良事件。给予2个疗程的FP维持化疗,完全缓解。目前,她患有食管狭窄;然而,在最初治疗9年后,她仍然存活且无复发。虽然dCRT对局部晚期食管癌有效,但其副作用可能持续存在。在此,我们报告了我们的病例,并纳入了相关的文献考虑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
337
期刊最新文献
[Online Survey about Communication between Abemaciclib-Treated Patients with Breast Cancer and Physicians]. [Survey on the Size of Oral Anticancer Drugs]. [Ⅰ. Personalized Perioperative Therapy in Luminal Breast Cancer]. [Ⅱ. Recurrence Score in Patients with BRCA1/2 Mutation from the OlympiA and TAILORx Trial Results]. [Ⅲ. MONARCH-E and Oncotype DX].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1